New research has found four genes with some of the largest known effects on the timing of menopause discovered to date, providing new insight into links between menopause timing and cancer risk.
Kyverna expands Series B with $60m to develop CAR-Ts for autoimmune disorders
Kyverna Therapeutics has added a further $60m as part of its Series B extension. Credit: Paul Craft via Shutterstock. US-based Kyverna Therapeutics has added a